Sana Biotechnology, Inc. (SANA) tiene un P/E histórico negativo de -3.3, lo que significa que la empresa actualmente no es rentable en base a los últimos doce meses (TTM). El rendimiento de ganancias histórico es -30.46%.
Criterios demostrados por esta página:
Puntuación General SharesGrow: 60/100 con 3/7 criterios aprobados.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendimiento por Dividendo |
|---|---|---|---|---|---|
| 2018 | -496.4 | 0.00 | -498.61 | 0.00 | - |
| 2019 | -50.3 | -0.06 | -46.13 | 0.00 | - |
| 2020 | -23.1 | -0.17 | -15.63 | 0.00 | - |
| 2021 | -7.2 | -0.23 | 3.54 | 0.00 | - |
| 2022 | -2.8 | 0.08 | 1.49 | 0.00 | - |
| 2023 | -2.8 | -1.34 | 2.76 | 0.00 | - |
| 2024 | -1.4 | 0.07 | 1.50 | 0.00 | - |
| 2025 | -4.2 | 0.24 | 6.41 | 0.00 | - |
| Year | EPS (Diluido) | Ingresos | Ingreso Neto | Margen Neto |
|---|---|---|---|---|
| 2018 | $-0.07 | $0.00 | $-13.25M | - |
| 2019 | $-0.70 | $0.00 | $-130.78M | - |
| 2020 | $-1.63 | $0.00 | $-285.31M | - |
| 2021 | $-2.14 | $0.00 | $-355.93M | - |
| 2022 | $-1.43 | $0.00 | $-269.48M | - |
| 2023 | $-1.46 | $0.00 | $-283.26M | - |
| 2024 | $-1.16 | $0.00 | $-266.76M | - |
| 2025 | $-0.96 | $0.00 | $-244.17M | - |
| Year | EPS (Prom.) | Rango EPS | Ingresos (Prom.) | Rango de Ingresos | Analistas |
|---|---|---|---|---|---|
| 2026 | $-0.63 | $-0.69 – $-0.54 | $0.00 | $0.00 – $0.00 | 6 |
| 2027 | $-0.65 | $-0.72 – $-0.48 | $6.95M | $6.95M – $6.95M | 5 |
| 2028 | $-0.69 | $-1.14 – $-0.51 | $19.8M | $19.8M – $19.8M | 6 |
| 2029 | $-0.83 | $-0.83 – $-0.83 | $4.98M | $4.98M – $4.98M | 4 |
| 2030 | $-0.73 | $-0.73 – $-0.73 | $26.25M | $26.25M – $26.25M | 2 |
